LAUSR

Bovine respiratory disease (BRD) causes significant economic losses to the feedlot industry due to decreased production and increased costs associated with treatment. This study aimed to assess the impacts of BRD on performance, carcass traits and economic outcomes defined using 4 BRD diagnosis methods; number of BRD treatments an animal received, pleural lesions at slaughter, lung lesions at slaughter, and clinical BRD status defined using both treatment records and lung and pleural lesions. Crossbred steers (n=898), with an initial body weight of 432 kg (± SD 51), were followed from feedlot entry to slaughter. Veterinary treatment records were collected and lungs scored at slaughter for lesions indicative of BRD. There was an 18% morbidity rate and a 2.1% BRD mortality rate, with an average net loss of $1647.53 per BRD mortality. Animals treated ≥ 3 times for BRD had 39.6 kg lighter carcasses at slaughter and returned an average of $384.97 less compared to animals never treated for BRD (P < 0.001). Animals with severe lung lesions at slaughter grew 0.3 kg/d less, had 14.3 kg lighter carcasses at slaughter and returned $91.50 less than animals with no lung lesions (P < 0.001). Animals with subclinical and clinical BRD had 16.0 kg and 24.1 kg lighter carcasses, respectively, and returned $67.10 and $213.90 less at slaughter, respectively, compared to healthy animals that were never treated with no lesions (P < 0.001). The severity of BRD based on the number of treatments an animal received and the severity of lung and pleural lesions reduced animal performance, carcass weight and quality, and economic returns. Subclinical BRD reduced animal performance and economic returns compared to healthy animals, however subclinical animals still had greater performance than animals with clinical BRD. This information can be used to plan for strategic investments aimed at reducing the impacts of BRD in feedlot cattle such as improved detection methods for subclinical animals with lesions at slaughter and BRD treatment protocols.